'Can you please answer my questions about their Wuhan lab and the current plasma collection activities in the US?'
I think you would probably need to get CSL to provide that advice...
Also when checking PE for CSL, you may want to adjust for RD costs being expensed vs if they were fully or partially capitalised.
Why $175?, your posts seem to imply coronavirus will destroy all of CSL's future earnings, and the ability to provide blood products... If this is the case CSL's PE, future earnings and share price should be last thing we all need to worry about..
CSL has more upside..., page-367
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$309.18 |
Change
-2.520(0.81%) |
Mkt cap ! $149.4B | |||
| Open | High | Low | Value | Volume |
| $309.97 | $311.31 | $307.86 | $126.5M | 409.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 852 | $309.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $309.18 | 741 | 2 |
View Market Depth
| Last trade - 16.10pm 22/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |